Pearl Avery from Dorset County Hospital shows very interesting data on the clinical validity and ease of use of the IBDoc® calprotectin home test at ECCO 2018.
Professor Russell Stothard and Dr Amaya Bustinduy Liverpool School of Tropical Medicine, London School of Hygiene and Tropical Medicine Our article highlights ongoing work in Uganda measuring morbidity associated with
At the European Crohn’s and Colitis Organisation, 13th Congress in Vienna in February 2018 Avery and Wilson of Dorset County Hospital Foundation Trust, Gastroenterology, Dorchester, UK presented the poster: IBDoc® Self-care/Point of care Calprotectin Test:
Mary O’Connell née Deasy, Biochemistry Department, Mercy University Hospital, Cork In issue 2017-3 of Leading Edge, Mary O’Connell detailed her evaluation of the BÜHLMANN fCAL® turbo assay on the Abbott Architect C8000 analyser in comparison
Using IBDoc Faecal Calprotectin Testing Post Induction of anti-TNF Therapy G. Elsafi et al. Department of Gastroenterology, Mercy University Hospital, Cork At UEGW in Barcelona in October 2017 Dr. Elsafi and
Mary O’Connell née Deasy, Biochemistry Department, Mercy University Hospital, Cork, Ireland The Mercy University hospital is one of the largest users of the IBDoc test, with almost 500 patients using the system to
On the 15th November 2017, Alpha Laboratories held a Digestive Diseases Day workshop. This educational day brought together experts in the field to discuss recent advances in clinical diagnostics for
Mary O’Connell née Deasy, Biochemistry Department Mercy University Hospital Cork, Ireland describes her experience introducing the BÜHLMANN fCAL turbo assay onto her department’s Abbott Architect C8000. At the Biochemistry Department
Turbo Charged from the Start Rosie Forster and Karen Smith, Clinical Biochemistry, Queen Elizabeth Hospital Birmingham introduce Faecal Calprotectin testing into their laboratory using the BÜHLMANN fCAL® turbo assay. Faecal
In this video Caroline Bello from the University Hospital in Liege, Belgium presents the data of BÜHLMANN’s multicenter study with over 50 patients in Liege (Prof. Edouard Louis), Oslo (Dr.
Comparison of Two Diagnostic Methods for Monitoring Inflammatory Bowel Disease. In this video Anke Heida, a PhD student from the IBD Centre, Groningen University Medical Center, Netherlands presents her poster at
Dr James Turvill, York Teaching Hospital NHS Foundation Trust discusses the York Faecal Calprotectin Care Pathway. Using Faecal Calprotectin Testing in Primary Care: Watch the Video. Calprotectin Testing in Primary
Interview with Anita Grünauer (BMA), Dr. Jasmin Barman-Aksözen (Head of Department Chemistry), and Predrag Nesic (Head of Department BMA Chemistry), Institute for Laboratory Medicine, City Hospital Triemli, Zurich …the BÜHLMANN
Interview with Mara Barbieru Deputy Senior Biomedical Analyst, Department of Clinical Chemistry and Biochemistry, Children’s Hospital of Zurich “For years, we had wanted to run Calprotectin in-house and now finally we can offer this.”
Interview with Yvonne Schallberger, Bioanalytica Lucerne 2. BÜHLMANN fCAL turbo Evaluation “By introducing BÜHLMANN fCAL® turbo we can finally provide the service the gastroenterologists of the St. Anna Hospital longed
There has been much interest in the BÜHLMANN fCAL turbo faecal calprotectin assay since its UK launch in early 2016. With the increasing demand for faecal calprotectin tests there is a
Pamela Bowe, Team Manager in the Department of Biochemistry at the Cumberland Infirmary describes her experience in evolving laboratory procedures and introducing BÜHLMANN fCAL turbo to cope with the growing number of faecal calprotectin
Louise Asser, Specialist Biomedical Scientist at Luton and Dunstable University Hospital tells us about the work there, following up patients with a false positive calprotectin result. Using a pill-sized camera
Julia Edin, a Crohn’s patient from Norway tells us about her experience using IBDoc® at home.
NEW User Report: Monitoring calprotectin concentrations is important as an indicator of disease activity, the effectiveness of treatment and to predict relapses in Inflammatory Bowel Disease (IBD).
As reported in the Daily Mail recently, misdiagnosis of IBS can have serious consequences. Read the full article The IBS Epidemic With one in ten people thought to be affected by
Crohn’s sufferer Lee Stanley from Manchester writes about his experience of living with Crohn’s Disease for 25 years. Why he feels regular calprotectin testing is important, and the benefits that
Introduction Calprotectin is a heterodimer of calcium-binding proteins which belongs to the S-100 protein family. It is released from neutrophils and monocytes during cellular activation (or death) at sites of
As the Director of the UK NEQAS programme for Faecal Markers of Inflammation, I’m often asked why we sometimes see quite large differences between the Faecal Calprotectin results obtained by
22 April 2013: NTAC (NHS Technology Adoption Centre) have published a report reviewing Faecal Calprotectin which is a simple diagnostic test which can aid clinicians to more accurately identify those
In this case study, Arne Roseth reflects on a case last year where he met a patient who’d been wrongly diagnosed with IBS over 16 years ago. Last July I
Dr Sean Nugent, Consultant Gastroenterologist,of The Whitfield Clinic, Waterford, Ireland, talks to us about his introduction of the Quantum Blue Calprotectin Test into his clinic. Alpha Labs: Can you describe
Successful laboratory assays are usually dependent on the alignment of many elements and sometimes things do go wrong despite everyones best efforts! Nik Hawes and Julia Bond from the Biochemistry
In autumn 2010, the Clinical Chemistry Dept at the Royal Berkshire Hospital decided to evaluate the Quantum Blue Calprotectin test. The reason was that their Calprotectin requests had grown sufficiently